Connect your AI

DocGo DCGO Trading securities, cost

Trading securities, cost at other companies

ARD

Ardent Health PartnersARDT

——

Other financials

Income statement

Revenue$75.6M-21.3%

Gross profit-$407.9M-25.6%

Operating income-$18.7M-33.7%

Net income-$14.8M-57.0%

EPS (diluted)-$0.15-66.7%

Balance sheet

Cash & equivalents$46.8M-54.6%

Total debt$28.5M-7.6%

Total equity$132.3M-57.2%

Total assets$209.2M-51.4%

Cash flow

Operating cash flow-$4.7M-151%

CapEx$430.3K-58.2%

Free cash flow-$5.1M-162%

Valuation

Market cap$50.98M-67.2%

Enterprise value$32.67M-59.1%

P/S0.2×-0.2×

Profitability

Operating margin-60.6%—

Net margin-62.2%—

FCF margin14.6%+8.1pp

Returns & leverage

Return on equity-85%—

Debt / equity0.2×+0.1×

Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's trading securities, cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is DocGo's trading securities, cost?: DocGo (DCGO) reported trading securities, cost of $0 in Q1 2026.
How has DocGo's trading securities, cost changed year-over-year?: DocGo's trading securities, cost decreased by 100.0% year-over-year, from $5M to $0.